114 related articles for article (PubMed ID: 15541278)
1. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell killing by in vitro affinity-matured recombinant human monoclonal antibodies.
Huls G; Gestel D; van der Linden J; Moret E; Logtenberg T
Cancer Immunol Immunother; 2001 May; 50(3):163-71. PubMed ID: 11419184
[TBL] [Abstract][Full Text] [Related]
3. Diversity of the antibody response to tetanus toxoid: comparison of hybridoma library to phage display library.
Sorouri M; Fitzsimmons SP; Aydanian AG; Bennett S; Shapiro MA
PLoS One; 2014; 9(9):e106699. PubMed ID: 25268771
[TBL] [Abstract][Full Text] [Related]
4. Generation of a murine single chain Fv (scFv) antibody specific for cucumber mosaic virus (CMV) using a phage display library.
Chae JS; Choi JK; Lim HT; Cha SH
Mol Cells; 2001 Feb; 11(1):7-12. PubMed ID: 11266124
[TBL] [Abstract][Full Text] [Related]
5. Chimeric antigen receptor T cells targeting the GM3(Neu5Gc) ganglioside.
Heinzelbecker J; Fauskanger M; Jonson I; Krengel U; Løset GÅ; Munthe L; Tveita A
Front Immunol; 2024; 15():1331345. PubMed ID: 38370401
[TBL] [Abstract][Full Text] [Related]
6. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.
Figini M; Martin F; Ferri R; Luison E; Ripamonti E; Zacchetti A; Mortarino M; Di Cioccio V; Maurizi G; Allegretti M; Canevari S
Cancer Immunol Immunother; 2009 Apr; 58(4):531-46. PubMed ID: 18704410
[TBL] [Abstract][Full Text] [Related]
7. Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays.
Gao C; Mao S; Lo CH; Wirsching P; Lerner RA; Janda KD
Proc Natl Acad Sci U S A; 1999 May; 96(11):6025-30. PubMed ID: 10339535
[TBL] [Abstract][Full Text] [Related]
8. T7 phage display reveals NOLC1 as a GM3 binding partner in human breast cancer MCF-7 cells.
Choi H; Kim HD; Choi YW; Lim H; Kim KW; Kim KS; Lee YC; Kim CH
Arch Biochem Biophys; 2023 Dec; 750():109810. PubMed ID: 37939867
[TBL] [Abstract][Full Text] [Related]
9. Phage display assisted discovery of a pH-dependent anti-α-cobratoxin antibody from a natural variable domain library.
Tulika T; Pedersen RW; Rimbault C; Ahmadi S; Rivera-de-Torre E; Fernández-Quintero ML; Loeffler JR; Bohn MF; Ljungars A; Ledsgaard L; Voldborg BG; Ruso-Julve F; Andersen JT; Laustsen AH
Protein Sci; 2023 Dec; 32(12):e4821. PubMed ID: 37897425
[TBL] [Abstract][Full Text] [Related]
10. Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells.
de Leòn J; Fernández A; Mesa C; Clavel M; Fernández LE
Cancer Immunol Immunother; 2006 Apr; 55(4):443-50. PubMed ID: 16208470
[TBL] [Abstract][Full Text] [Related]
11. Problems of creating antibody phage libraries and their solutions.
Aripov VS; Volkova NV; Ilyichev AA; Shcherbakov DN
Vavilovskii Zhurnal Genet Selektsii; 2024 Apr; 28(2):249-257. PubMed ID: 38680186
[TBL] [Abstract][Full Text] [Related]
12. Progress on Phage Display Technology: Tailoring Antibodies for Cancer Immunotherapy.
França RKA; Studart IC; Bezerra MRL; Pontes LQ; Barbosa AMA; Brigido MM; Furtado GP; Maranhão AQ
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766309
[TBL] [Abstract][Full Text] [Related]
13. Engineered Autonomous Human Variable Domains.
Nilvebrant J; Tessier PM; Sidhu SS
Curr Pharm Des; 2016; 22(43):6527-6537. PubMed ID: 27655414
[TBL] [Abstract][Full Text] [Related]
14. Construction of Antibody Phage Libraries and Their Application in Veterinary Immunovirology.
Bashir S; Paeshuyse J
Antibodies (Basel); 2020 Jun; 9(2):. PubMed ID: 32503103
[TBL] [Abstract][Full Text] [Related]
15. Intracellular antibodies and cancer: new technologies offer therapeutic opportunities.
Pérez-Martínez D; Tanaka T; Rabbitts TH
Bioessays; 2010 Jul; 32(7):589-98. PubMed ID: 20544739
[TBL] [Abstract][Full Text] [Related]
16. Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours.
Kotlan B; Plotar V; Eles K; Horvath S; Balatoni T; Csuka O; Újhelyi M; Sávolt Á; Szollar A; Vamosi-Nagy I; Toth L; Farkas E; Toth J; Kasler M; Liszkay G
Contemp Oncol (Pozn); 2018 Mar; 22(1A):41-47. PubMed ID: 29628793
[TBL] [Abstract][Full Text] [Related]
17. Structure based antibody-like peptidomimetics.
Murali R; Greene MI
Pharmaceuticals (Basel); 2012 Feb; 5(2):209-35. PubMed ID: 24288089
[TBL] [Abstract][Full Text] [Related]
18. Expression of recombinant antibodies.
Frenzel A; Hust M; Schirrmann T
Front Immunol; 2013; 4():217. PubMed ID: 23908655
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic ribosome display for antibody discovery: A review.
Chance R; Kang AS
Hum Antibodies; 2024 May; ():. PubMed ID: 38788063
[TBL] [Abstract][Full Text] [Related]
20. Light chain shuffling of a high affinity antibody results in a drift in epitope recognition.
Ohlin M; Owman H; Mach M; Borrebaeck CA
Mol Immunol; 1996 Jan; 33(1):47-56. PubMed ID: 8604223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
